Lumida
/ATOS
⌘K
Atossa Therapeutics Inc

Atossa Therapeutics Inc

ATOS
$2.51USD+7.26%+0.17 today

MARKET CAP

25.0M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $3

52W RANGE

$2
$19
STATEMENT·Income statement
USD · GAAP
METRICFY 2012FY 2013FY 2014FY 2015TREND
Sales, Adj.$481,842$632,558$40,138$1,758
YoY %+31.3%-93.7%-95.6%
P / Sales100.8x56.8x856.4x931413.6x
EV / Sales100.6x49.0x701.1x930722.9x
Gross Profit, Adj.$446,097$287,039$40,138$-130,653
YoY %-35.7%-86.0%-425.5%
Margin %92.6%45.4%100.0%-7431.9%
EV / Gross Profit108.7x108.0x701.1x-12523.3x
EBITDA, Adj.$-4.9M$-10.2M$-9.3M$-12.5M
YoY %-107.0%+8.1%-33.7%
Margin %-1018.7%-1606.5%-23265.0%-710238.4%
EV / EBITDA-9.9x-3.0x-3.0x-131.0x
EBIT$-5.1M$-10.8M$-12.2M$-12.8M
YoY %-112.8%-12.9%-4.8%
Margin %-1052.0%-1704.9%-30323.0%-725746.2%
EV / EBIT-9.6x-2.9x-2.3x-128.2x
Net Income$-5.1M$-10.8M$-14.7M$-15.8M
YoY %-112.3%-35.9%-7.5%
Net Margin-1054.3%-1704.9%-36518.8%-896491.6%
EPS (GAAP)-$1107.00-$1890.00-$1647.00-$1495.80
YoY %-70.7%+12.9%+9.2%